20/20 Biolabs, Inc. (AIDX) reporting calendar
20/20 Biolabs, Inc. files periodic reports with the SEC as AIDX on Nasdaq. Atlas tracks 2 filed reports for this issuer, each linked to its original EDGAR accession.
- Latest report
- 10-Q
- Period ended
- 31 Mar 2026
- Filed
- 20 May 2026
- Reports on record
- 2
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 10-Q | 31 Mar 2026 | 20 May 2026 | 50 days | 0001213900-26-059542 |
| 10-K | 31 Dec 2025 | 31 Mar 2026 | 90 days | 0001213900-26-037667 |
Source: SEC EDGAR company submissions for CIK 0001139685. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.